News

Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here ...
Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today shared how its flexible partner ecosystem is enabling K-12 independent schools to transform their ...